Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat’s Gut Microbiome Effects from Other Anti-CDI Antibiotics
First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model Changes... Read more.
Gen Mobile Announces Major Plan Upgrade: More Data, More International, More Value!
EL SEGUNDO, Calif., March 3, 2025 /PRNewswire/ — Gen Mobile, a leading provider of prepaid wireless phone service, today announced significant updates to its... Read more.
FinThrive and HIMSS Survey Reveals Cybersecurity Funding is a Top Challenge for Smaller Hospitals
The survey of healthcare leaders identifies how providers are defending against growing cyber threats and the greatest barriers to their ongoing security PLANO,... Read more.
New Water Capital Acquires Dutch Gold Honey and Related Businesses
BOCA RATON, Fla., March 3, 2025 /PRNewswire/ — An affiliate of New Water Capital Partners II L.P. (“New Water” or “the Firm”), a Boca... Read more.
Arbe to Present at 37th Annual Roth Conference
TEL AVIV, Israel, March 3, 2025 /PRNewswire/ — Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced... Read more.
MicroCloud Hologram Inc. Announces It Has Purchased Up to $200 Million in Bitcoin and Cryptocurrency-Related Securities Derivatives, with Total Accumulated Dividends Reaching $8.13 Million
SHENZHEN, China, March 3, 2025 /PRNewswire/ — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service... Read more.
Actian Advances Data Intelligence Platform
Platform addresses enterprise need for accelerated data discovery, self-service access, strong datagovernance, and improved collaboration for the AI era ROUND ROCK,... Read more.
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
SAN JOSE, Calif., March 3, 2025 /PRNewswire/ — Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company... Read more.
symplr Launches symplrAI Evidence Analysis Application for New Operations Platform on AWS
AI-powered solution leverages data in the symplr Operations Platform to evaluate new medical devices or technologies HOUSTON, March 3, 2025 /PRNewswire/ —... Read more.
More Canadians to benefit from skills development through expansion of promising solutions by Future Skills Centre
AURORA, ON, March 3, 2025 /CNW/ – The Future Skills Centre (FSC) is pleased to announce a new investment of $14.3 million to expand more than a dozen innovative... Read more.